NEWARK, Del, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Global Heart Block Therapeutics Market was valued at US$ 3 Bn in 2021 and is expected to reach US$ 4.8 Bn by 2032, find Future Market Insights (FMI) in a recent market survey. As per the findings of the report, Pacemakers, among all products will garner significant demand in the market as the bulk of revenue will be generated through them. Revenue through pacemakers grew at a CAGR of 4.8% during 2015 - 2021.
Older Populace Swells Worldwide, Propels the Global Demand for Heart Block Therapeutics
According to the United Nations Department of Economic and Social Affairs, by 2050, the population of 60 years old and above is expected to reach 437 Mn in China, 324 Mn in India, 107 Mn in The US, and 58 Mn in Brazil. Hence, the growing older populace propels the worldwide Heart Block Therapeutics market as the older population is more prone to heart-related diseases. The World Health Organization (WHO) reported that around 524 Mn people represent the geriatric population in 2010 and by 2050, almost 2 Bn people will be geriatric.
The US Continues Being the Largest Revenue Stream for Heart Block Therapeutics Market
Heart Block Therapeutics market in the US to reach a valuation of US$ 1.7 Bn by 2032. From 2015 to 2021, the market revenue through the US grew at a CAGR of 4.7%, while between 2022 and 2032, it is predicted to witness a CAGR of 4.1%. The combination of innovative treatment technology, adoption of digital solutions, and shifting provider and care delivery shifts provides the Heart Block Therapeutics Industry with tremendous growth potential in the United States. Between 2022 and 2032, the US is expected to be a market with a US$ 570.5 Mn absolute dollar opportunity.
Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15097
“Introduction of artificial intelligence technology in the Heart Blockage surgeries will be the biggest step towards increasing the revenue growth of Heart Block Therapeutics Market” comments an analyst at Future Market Insights.
Heart Block Therapeutics Market: Competition Insights
The key companies dominating the Heart Block Therapeutics Market are St. Jude Medical, Medtronic, Bristol Myers Squibb, Novartis AG, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Edward Lifesciences Corporation, Abbott Laboratories, Natco Pharma, Pfizer Inc., Bayer AG, Astra Zeneca, Sanofi, Merck & Co., Inc., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd.
Some of the recent developments by the key providers of Heart Block Therapeutics are as follows:
- In April 2022, Bristol Myers Squibb announced that they have received approval from US Food and Drug Corporation for its oral heart disease drug Mavacamten which will help in treating hypertrophic cardiomyopathy, a genetic heart disease that leads to sudden cardiac arrests in young people.
- In June 2020, Edward Lifesciences Corporation (USA) confirmed that they have received Chinese approval for the SAPIEN 3 Trans catheter heart valve for the treatment of patients with severe and symptomatic aortic stenosis (AS) who are not able to undergo open-heart surgery.
- In September 2019, Medtronic (USA) Received US Food and Drug Corporation clearance for its Next Generation Evolut PRO+ TAVR System for the Treatment of Symptomatic Severe Aortic Stenosis in Patients. The Evolut PRO+ TAVR System includes four valve sizes with an external pericardial tissue wrap that provides advanced sealing for the largest indicated patient treatment range and the lowest delivery profile currently on the market.
- In March 2019, Abbott (USA) Received US Food and Drug Corporation Clearance Anthos Therapeutics for Cardiovascular Drug Development which focused on advancing next-generation targeted therapies for high-risk cardiovascular patients.
- In February 2019, Novartis AG and Blackstone’s Life sciences announced the launch of Anthos Therapeutics for the development of cardiovascular drugs. As part of this launch, Novartis has licensed to Anthos MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway.
- In January 2019, India-based Natco Pharma announced the launch of valsartan sacubitril, a cardiovascular drug that is used to treat congestive heart failure in patients.
Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15097
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Heart Block Therapeutics Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals extensive growth in Heart Block Therapeutics Market in terms of Type (First-degree Heart Blocks, Second-degree Heart Blocks, Third-degree Heart Blocks); Product (Transcutaneous Pacing, Pacemaker, Mediation, Follow-up Electrophysiology Study ); End User (Hospital Testing, Home Treatment, Clinics, Others) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Key Segments Covered in Heart Block Therapeutics Market Survey
By Type:
- First Degree Heart Blocks
- Second Degree Heart Blocks
- Third Degree Heart Blocks
By Product:
- Transcutaneous pacing (TCP)
- Pacemaker
- Mediation
- Follow-up electrophysiology study
By End User:
- Hospital Testing
- Home Treatment
- Clinics
- Others
By Region:
- North America
- Europe
- APAC
- MEA
- Latin America
Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15097
About the Healthcare Division at Future Market Insights
Future Market Insights' highly experienced healthcare and pharma team aids companies from all over the world with their specific business intelligence needs through professional research, actionable insights, and strategic recommendations. With a library of over a thousand research and 1 million+ data points, the team has spent over a decade analyzing the healthcare business across 50+ countries. From start to end, the company provides unrivaled research and consulting services. Please get in touch with us to see how we can help
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Heart Block Therapeutics
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
Have a Look at Related Research Reports of Healthcare
Total Artificial Heart Market Forecast: Total Artificial Heart Market : Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030
Leukemia Therapeutics Treatment Market Sale: During the forecast period, the leukemia therapeutics treatment market is expected to record a CAGR of 7.1 per cent to reach a valuation of US$ 17 Bn by 2024, from a valuation of US$ 13 Bn in 2020
Lung Cancer Therapeutics Market Growth: The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Mn by 2026, exhibiting a CAGR of 13.4% in the forecast period
Transcatheter Heart Valve Replacement (TAVI) Market Value: The transcatheter heart valve replacement market is predicted to advance at an impressive CAGR of 12% from 2022 to 2032
Continuous Peripheral Nerve Block Catheter Market Type: Continuous Peripheral Nerve Block Catheter Market: Stimulating Catheters to Reach a Noteworthy Valuation by the End of the Year of Assessment 2027
ABOUT FUTURE MARKET INSIGHTS, INC.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
